Antigen preservation in infarcted nodal B-cell lymphoma, with special reference to follicular center cell markers

International Journal of Surgical Pathology

Volumn 12, Issue 3, 2004, Pages 251-255

  Kojima, Masaru ^a,b   Nakamura, Shigeo ^c   Yamane, Yuko ^a   Nishikawa, Masafumi ^d   Murayama, Kayoko ^a   Shimizu, Kazuhiko ^e   Itoh, Hideaki ^f   Masawa, Nobuhide ^b  

^a GUNMA CANCER CENTER HOSPITAL   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d NASU RED CROSS HOSPITAL   (Japan)

^e ASHIKAGA RED CROSS HOSPITAL   (Japan)

^f MAEBASHI RED CROSS HOSPITAL   (Japan)

Author keywords

Diffuse large B cell lymphoma; Follicular lymphoma; Immunohistochemistry; Infarction; Lymph lymph node; Malignant lymphoma

Indexed keywords

CD20 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY; ONCOPROTEIN; POLYCLONAL ANTIBODY; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFARCTION; LARGE CELL LYMPHOMA; LYMPHOID TISSUE; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIGENS; ANTIGENS, CD20; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFARCTION; LYMPH NODES; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEPRILYSIN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 4043075513     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690401200306     Document Type: Article

References (16)

1. Davies JD, Stansfeld AG. Spontaneous infarction of superficial lymph nodes. J Clin Pathol 25:689-696, 1972
2. Clearry KR, Osborne BM, Butler JJ. Lymph node infarction foreshadowing malignant lymphoma, Am J Surg Pathol 6:435-442, 1982
3. Maurer R, Schmid U, Davies JD, Mahy J, Stansfeld AG, Lukes RJ, Lymph node infarction and malignant lymphoma: A multicentre survey of European, English and American cases. Histopathology 10:571-588, 1986
4. Ioachim HL, Ratech H. Ioachim's lymph node pathology, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, pp. 271-273, 2002
5. Frizzera G, Wu CD, Inghirami G. The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms, Am J Clin Pathol 111(Suppl 1):13-39, 1999
6. Norton AJ, Ramsay AD, Isaacson PG. Antigen preservation in infarcted lymphoid tissue: A novel approach to the infarcted lymph node using monoclonal antibodies effective in routinely processed tissues. Am J Surg Pathol 12:759-767, 1988
7. Strauchen JA, Miller LK. Lymph node infarction. An immunohistochemical study of 11 cases. Arch Pathol Lab Med 127:60-63, 2003
8. Dogan A, Bagdi E, Munson P, Isaacson PG. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 24:846-852, 2000
9. King BE, Chen C, Locker J, Kant J, Okuyama K, Falini B, Swerdlow SH. Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas. Mod Pathol 13:1219-1231, 2000
10. Ree HJ, Yang WI, Kim CW, Huh J, Lee S-S, Cho EY, Ko Y-H, Charney D. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: Significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma. Hum Pathol 32:954-962, 2001
11. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 36:69-87, 2000
12. Coiffer B, Haioun N, Kettereer N, Engert A, Tilly H, Ma D, Johnson P, Lister A, Feuring-Buske M, Radford JA, Capdeville R, Diehl V, Reyes F. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study. Blood 92:1927-1932, 1998
13. Pileri SA, Dirnhofer S, Went Ph, Ascani S, Sabattini E, Marafioti T, Tzankov A, Leoncini L, Falini B, Zinzani PL. Diffuse large B-cell lymphoma: One or more entities? Present controversies and possible tools for its subclassification. Histopathology 41:482-509, 2002
14. Allzadeh AA, Elsen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tlbshfrani R, Sherlock G, Chan WC, Greiner TC, Weisenberger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. Distinct type of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511, 2000
15. Wang T, Lasota J, Hanau CA, Miettinen M. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphoma but its different expression in benign versus malignant follicles and monocytoid B-cell proliferation is of diagnostic value. APMIS 103:655-662, 1995
16. Lai R, Arber DA, Chang KL, Wilson'CS, Weiss LM. Frequency of bcl-2 expression in nonHodgkin's lymphoma: A study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 11:864-869, 1998